Stock Analiz

Merck & Co., Inc. (MRK) stock forecast and price target

Price $147.76 · data as of November 13, 2026

12-month price target

Average target$161.53
Upside / downside+9.3%
Analysts26
ConsensusBuy
Low $105.00Average $161.53High $186.00

Gold marker: average target · white marker: today’s price ($147.76)

Analyst ratings

Strong buy 5Buy 14Hold 9Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$2.78−69.0%$67.2B
Next fiscal year
ends December 31, 2027
$8.98+223.1%$69.5B
Next quarter
ends December 31, 2026
$1.76−13.8%$16.3B
Quarter after
ends March 31, 2027
$2.13+266.3%$16.4B

Consensus of the analysts covering Merck & Co., updated daily. In the last 30 days 19 estimates were raised and 4 lowered.

Our model vs. Wall Street

Analysts see 9.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Merck & Co.’s intrinsic value about 31% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Merck & Co. stock price target?

The average 12-month target from 26 analysts is $161.53, 9.3% above the current price of $147.76 Targets range from $105.00 to $186.00.

Is Merck & Co. a buy according to analysts?

The consensus rating is “Buy” (5 strong buy, 14 buy, 9 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Merck & Co. expected to earn?

Analysts expect EPS of $2.78 for the fiscal year ending December 31, 2026 and $8.98 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.